Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity

被引：0
|
作者：
Gruber, M. L. [1 ,2 ,3 ]
Raza, S. [1 ,2 ,3 ]
Gruber, D. [1 ,2 ,3 ]
Narayana, A. [1 ,2 ,3 ]
机构：
[1] NYU, Ctr Clin Canc, New York, NY USA
[2] NYU, Med Ctr, New York, NY 10016 USA
[3] NYU, Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2017
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma
    Hemi Malkki
    [J]. Nature Reviews Neurology, 2014, 10 (4) : 179 - 179
  • [2] Phase III Trial of Bevacizumab Added to Standard Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Final Progression-Free Survival and Preliminary Overall Survival Results from AVAglio
    Cloughsey, Timothy
    Wick, Wolfgang
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Hilton, Magalie
    Abrey, Lauren
    Chinot, Olivier
    [J]. NEUROLOGY, 2013, 80
  • [3] PHASE III TRIAL OF BEVACIZUMAB ADDED TO STANDARD RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA: MATURE PROGRESSION-FREE SURVIVAL AND PRELIMINARY OVERALL SURVIVAL RESULTS IN AVAGLIO
    Chinot, Olivier
    Wick, Wolfgang
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Hilton, Magalie
    Abrey, Lauren
    Cloughesy, Timothy
    [J]. NEURO-ONCOLOGY, 2012, 14 : 101 - 101
  • [4] Phase III Trial of Bevacizumab Added to Standard Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Final Progression-Free Survival and Preliminary Overall Survival Results from AVAglio
    Cloughsey, Timothy
    Wick, Wolfgang
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Hilton, Magalie
    Abrey, Lauren
    Chinot, Olivier
    [J]. NEUROLOGY, 2013, 80
  • [5] OUTCOMES AND PREDICTORS OF SURVIVAL FOLLOWING CONCOMITANT AND ADJUVANT TEMOZOLOMIDE WITH RADIOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Swaminath, A.
    McMillan, W.
    McCarter, H.
    Hirte, H.
    Whitton, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S52 - S52
  • [6] Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
    Vieito, Maria
    Simonelli, Matteo
    de Vos, Filip
    Moreno, Victor
    Geurts, Marjolein
    Lorenzi, Elena
    Macchini, Marina
    van den Bent, Martin J.
    Del Conte, Gianluca
    de Jonge, Maja
    Martin-Soberon, Maria Cruz
    Amoroso, Barbara
    Sanchez-Perez, Tania
    Zuraek, Marlene
    Hanna, Bishoy
    Aronchik, Ida
    Filvaroff, Ellen
    Chang, Henry
    Mendez, Cristina
    Arias Parro, Marina
    Wei, Xin
    Nikolova, Zariana
    Sepulveda, Juan Manuel
    [J]. NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [7] Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
    Polley, Mei-Yin C.
    Lamborn, Kathleen R.
    Chang, Susan M.
    Butowski, Nicholas
    Clarke, Jennifer L.
    Prados, Michael
    [J]. NEURO-ONCOLOGY, 2010, 12 (03) : 274 - 282
  • [8] Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
    Stupp, R
    Dietrich, PY
    Kraljevic, SO
    Pica, A
    Maillard, I
    Maeder, P
    Meuli, R
    Janzer, R
    Pizzolato, G
    Miralbell, R
    Porchet, F
    Regli, L
    de Tribolet, N
    Mirimanoff, RO
    Leyvraz, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1375 - 1382
  • [9] Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
    Schiff, David
    Huse, Jason
    Wen, Patrick
    [J]. NEURO-ONCOLOGY, 2014, 16 (06) : 769 - 769
  • [10] Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
    Chinot, Olivier L.
    Wick, Wolfgang
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Carpentier, Antoine F.
    Hoang-Xuan, Khe
    Kavan, Petr
    Cernea, Dana
    Brandes, Alba A.
    Hilton, Magalie
    Abrey, Lauren
    Cloughesy, Timothy
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (08): : 709 - 722
12345